Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohit Butaney

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.
Clinical Genitourinary Cancer|July 23, 2022
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc AnalysisNicholas J Corsi, Edward M Messing, Akshay Sood, et al.
Clinical Genitourinary Cancer|January 17, 2024
Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision MakingDeepansh Dalela, Nicholas J Corsi, Chandler Bronkema, et al.
Urology|June 23, 2023
Building a Roadmap for Surveillance of Renal Masses Using a Modified Delphi Method to Help Achieve ConsensusAmit K Patel, Mohit Butaney, Brian R Lane, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Cancer Immunology Research|October 1, 2015
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung TumorsClaudia Voena, Matteo Menotti, Cristina Mastini, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.
Clinical Genitourinary Cancer|July 23, 2022
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc AnalysisNicholas J Corsi, Edward M Messing, Akshay Sood, et al.
Clinical Genitourinary Cancer|January 17, 2024
Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision MakingDeepansh Dalela, Nicholas J Corsi, Chandler Bronkema, et al.
Urology|June 23, 2023
Building a Roadmap for Surveillance of Renal Masses Using a Modified Delphi Method to Help Achieve ConsensusAmit K Patel, Mohit Butaney, Brian R Lane, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Cancer Immunology Research|October 1, 2015
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung TumorsClaudia Voena, Matteo Menotti, Cristina Mastini, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Pageof 8